I-MED Radiology’s latest acquisition is ‘independent’ of IPO preparation strategy
CEO Shrey Viranna said the Australia and New Zealand combined diagnostic imaging network’s IPO preparations provide “options” to its PE backer.
I-MED’s acquisition of Radiology Group comes as it inches towards an IPO, with CEO Shrey Viranna explaining the deal supports the company’s sustainable growth and is separate from its private equity backer Permira’s consideration of offloading the business.
“We’ve always taken a view on our growth, around it being sustainable and the right answer for the business we run and the patients we serve, which is independent of a transaction or change in shareholding, should that ever happen,” Viranna told Capital Brief.
Viranna said preparations for an IPO commenced in November, with the company in the midst of selecting an additional investment banking partner alongside Jefferies and Morgan Stanley, according to The Australian.
The publication had earlier reported that potential suitors Macquarie Asset Management and Bain Capital walked away from takeover talks in 2024, while negotiations with Stonepeak ended in 2025.
